For research use only. Not for therapeutic Use.
M3913（Cat No.:I041286）is a potent, selective inhibitor designed for research in cancer and metabolic disease therapies. It targets key enzymes involved in cellular signaling pathways, particularly in the regulation of glucose metabolism and cell proliferation. By modulating these pathways, M3913 demonstrates potential in inhibiting tumor growth and improving metabolic control. Its unique mechanism of action makes it a valuable tool for studying cancer progression and metabolic disorders. Researchers can use M3913 to explore novel therapeutic strategies for cancer and metabolic diseases, providing insights into disease mechanisms and treatment opportunities.
| CAS Number | 2379783-62-5 |
| Synonyms | 4-[(3S)-3-(2-chloro-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine |
| Molecular Formula | C17H21ClN4O3S |
| Purity | ≥95% |
| IUPAC Name | 4-[(3S)-3-(2-chloro-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine |
| InChI | InChI=1S/C17H21ClN4O3S/c1-11-8-16(21-17(19)20-11)22-6-3-7-25-10-15(22)13-5-4-12(9-14(13)18)26(2,23)24/h4-5,8-9,15H,3,6-7,10H2,1-2H3,(H2,19,20,21)/t15-/m1/s1 |
| InChIKey | BRVSQKUHXCLBQJ-OAHLLOKOSA-N |
| SMILES | CC1=CC(=NC(=N1)N)N2CCCOC[C@@H]2C3=C(C=C(C=C3)S(=O)(=O)C)Cl |
